scispace - formally typeset
B

Bernard Bihain

Researcher at French Institute of Health and Medical Research

Publications -  80
Citations -  5047

Bernard Bihain is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Receptor & Lipoprotein. The author has an hindex of 28, co-authored 79 publications receiving 4850 citations. Previous affiliations of Bernard Bihain include Umeå University & University of Rennes.

Papers
More filters
Journal ArticleDOI

Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice

TL;DR: Daily administration of a very low dose of gAcrp30 to mice consuming a high-fat/sucrose diet caused profound and sustainable weight reduction without affecting food intake.
Journal ArticleDOI

Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia.

TL;DR: In normal subjects, VLDL concentration determines the rate of net CE transfer, and CETP becomes rate limiting as V LDL concentration increases, i.e., in hypertriglyceridemia.
Journal ArticleDOI

Fatty acid control of lipoprotein lipase: a link between energy metabolism and lipid transport.

TL;DR: It is suggested that in situations when fatty acids are generated more rapidly by LPL than they are used by the local tissue, they cause dissociation of the enzyme from its binding to endothelial heparin sulfate and are themselves released into circulation.
Journal ArticleDOI

Predictive value of skin prick tests using recombinant allergens for diagnosis of peanut allergy.

TL;DR: Skin prick tests to individual recombinant peanut allergens appear to be a safe and effective diagnostic tool and monosensitization to rAra h 2 and rArah 1 and/or rARA h 3 is predictive of more severe reactions.
Journal ArticleDOI

A Novel Immunoassay Using Recombinant Allergens Simplifies Peanut Allergy Diagnosis

TL;DR: A simple blood test can be used to diagnose peanut allergy with a high level of precision, and Double-blind placebo-controlled food challenge will remain useful for the few cases where immunological and clinical observations yield conflicting results.